Back to IKT

JPMORGAN CHASE & CO → IKT

JPMORGAN CHASE & CO IKT Position History

Inhibikase Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$2K
Q3 2026
Peak value
$487K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$41K
Q3 2025$39K
Q3 2025$219
Q4 2025$949
Q4 2025$50K
Q4 2025$476
Q1 2026$430K
Q1 2026$89K
Q1 2026$717
Q2 2026$121K
Q2 2026$487K
Q2 2026$4K
Q3 2026$160K
Q3 2026$486K
Q3 2026$2K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2K928——
Q3 2026$486K240.7K——
Q3 2026$160K79.4K——
Q2 2026$4K1.9K——
Q2 2026$487K252.1K——
Q2 2026$121K62.6K——
Q1 2026$717454——
Q1 2026$89K56.1K——
Q1 2026$430K271.9K——
Q4 2025$476232——
Q4 2025$50K24.2K——
Q4 2025$949463——
Q3 2025$219135——
Q3 2025$39K24.4K——
Q3 2025$41K25.4K——

Other funds holding IKT

Other JPMORGAN CHASE & CO positions

NVDA

NVIDIA CORPORATION

$62.5B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.2B
NVDA

NVIDIA CORPORATION

$53.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$49.4B